John W Smither
CIK 1559583 · View on SEC EDGAR ↗
First SEC filing: Dec. 29, 2023 · Latest: Dec. 29, 2023
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 1, 2026 | GNLX | S | 12,000 | $2.91 | $34,920 | 91,403 Direct | -11.61% | Disposed | -6.0% (price as of 2026-08-20) |
| Sept. 13, 2023 | GNLX | S | 900 | $20.78 | $18,702 | 6,920 Direct | -11.51% | Disposed | -86.8% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 3, 2026 | MBX | Stock option (right to buy) | Common Stock (130,000) | $64.41 | Aug. 3, 2036 | 130,000 | Acquired |
| June 16, 2026 | GNLX | Stock Option (Right to Buy) | Common stock (31,566) | $3.03 | June 15, 2036 | 31,566 | Acquired |
| Jan. 7, 2026 | NAMSW | Option (right to buy) | Ordinary Shares (15,300) | $35.45 | Jan. 7, 2036 | 15,300 | Acquired |
| Jan. 6, 2025 | NAMSW | Option (right to buy) | Ordinary Shares (32,500) | $25.85 | Jan. 6, 2035 | 32,500 | Acquired |
| Jan. 1, 2024 | NAMSW | Option (right to buy) | Ordinary Shares (10,000) | $11.17 | Jan. 1, 2034 | 10,000 | Acquired |
| Sept. 11, 2023 | GNLX | Stock Option (Right to Buy) | Common Stock (8,447) | $22.40 | Sept. 10, 2033 | 8,447 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 13 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 4, 2026 | ATTO | Stock Option (Right to Buy)→ Common Stock (72,792) | 72,792 | Direct |
| Dec. 29, 2023 | NAMSW | Option (right to buy)→ Ordinary Shares (18,600) | 18,600 | Direct |
| Sept. 13, 2023 | GNLX | Common Stock | 900 | Direct |
| Sept. 5, 2023 | ARQT | Common Stock | 141,392 | Indirect |
| Sept. 5, 2023 | ARQT | Stock Option (right to buy)→ Common Stock (33,602) | 33,602 | Direct |
| Sept. 5, 2023 | ARQT | Stock Option (right to buy)→ Common Stock (40,482) | 40,482 | Direct |
| Sept. 5, 2023 | ARQT | Stock Option (right to buy)→ Common Stock (8,379) | 8,379 | Direct |
| Sept. 5, 2023 | ARQT | Stock Option (right to buy)→ Common Stock (25,718) | 25,718 | Direct |
| Sept. 5, 2023 | ARQT | Stock Option (right to buy)→ Common Stock (4,165) | 4,165 | Direct |
| Jan. 30, 2020 | ARQT | Common Stock | 99,965 | Direct |
| Jan. 30, 2020 | ARQT | Stock Option (Right to Buy)→ Common Stock (124,955) | 124,955 | Direct |
| Jan. 30, 2020 | ARQT | Stock Option (Right to Buy)→ Common Stock (49,982) | 49,982 | Direct |
| Jan. 30, 2020 | ARQT | Stock Option (Right to Buy)→ Common Stock (14,994) | 14,994 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $183,333 | — | $1,053,771 | $759,714 | $105,600 | — | — | $2,102,418 |
| 2021 | $100,000 | — | $755,233 | $5,384,317 | — | — | $10,752 | $6,250,292 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.